How ageing populations can change a pathogen’s deadliness

Global populations are getting older at an unprecedented pace, and age is a major factor in who gets infected, who gets sick, and who dies. Tom J. Little and collaborators used this basic fact as the starting point for a question rooted in evolutionary biology: as the age structure of human populations shifts, how might pathogens adjust their level of harm — their virulence — to exploit those new host landscapes? To explore that question, the team built an age-specific R 0 model and tuned it with 2017 epidemiological data for four very different infections: Measles, Tuberculosis, Meningitis, and Ebola. They combined those disease data with age-specific demographic estimates for 2017 and projections for 2050 across the seven Global Burden of Disease super-regions. The approach treats pathogens as evolving entities that face trade-offs: being more harmful can sometimes help transmission, but it can also shorten infectious periods or kill hosts before they spread the disease. By putting those pieces together, the researchers set out to predict how shifting age structures might alter the optimal level of virulence a pathogen would evolve to maintain itself in a population.

The study examined two theoretical trade-offs that shape pathogen strategy: virulence versus transmission, and virulence versus host recovery. To explore a wide range of possible relationships between those factors, the team parameterised the trade-off parameters using Latin Hypercube Sampling, a method for efficiently sampling many combinations of variables. They applied that sampling inside the age-specific R 0 model, driven by open-access disease data and demographic inputs for 2017 and 2050 across the seven Global Burden of Disease super-regions. The results were not uniform: population ageing between 2017 and 2050 was associated with increased virulence-induced mortality in four specific settings: Ebola in sub-Saharan Africa; Measles in the central/eastern Europe & central Asia region; Measles in North Africa & the Middle East; and Tuberculosis in the central/eastern Europe & central Asia region. In other regions and disease pairings, the model pointed the other way: the increase in background mortality and the resulting decrease in infection duration as more people are elderly drove predicted pathogen virulence down.

These findings show that demographic change can push pathogen evolution in different directions depending on disease biology and regional age structures. For some infections in some regions, an older population could unintentionally favor strains that cause greater harm, increasing virulence-induced deaths; for others, shorter infectious periods among older hosts or higher background mortality could select for milder strains. The work highlights that infectious-disease dynamics are nonlinear and context-dependent: the same global force — ageing — does not produce a single global outcome. Understanding the mechanisms that shape pathogen dynamics, and using models like this to anticipate how virulence might shift, is presented by Tom J. Little and colleagues as a key tool for planning in a rapidly changing world. Such foresight can help public health decision-makers target surveillance and tailor responses as populations age and endemic diseases persist.